C. Taylor

发表

Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging.

R. Gillies, M. Altbach, J. Galons, 1999, Neoplasia.

R. Gillies, N. Raghunand, Z. Bhujwalla, 2022 .

Effects of interleukin-4 on the in vitro growth of human lymphoid and plasma cell neoplasms.

T. Grogan, C. Taylor, S. Salmon, 1990, Blood.

Cardiac Side-effects From Breast Cancer Radiotherapy.

C. Taylor, A. Kirby, Anna M. Kirby, 2015, Clinics in oncology.

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

P. Meltzer, T. Grogan, T. Miller, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haloperidol versus thioridazine for the treatment of psychogeriatric patients: A double-blind clinical trial.

C. Taylor, G. R. Smith, P. Linkous, 1974 .

Long-term engraftment of fresh human myeloma cells in SCID mice.

T. Grogan, C. Taylor, E. Hersh, 1992, Blood.

Amifostine protects normal tissues from paclitaxel toxicity while cytotoxicity against tumour cells is maintained.

G. Paine-Murrieta, C. Taylor, A. List, 1997, European journal of cancer.

High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4–9 involved axillary lymph nodes

B. Overmoyer, C. Taylor, E. Shpall, 1997, Bone Marrow Transplantation.

Multicenter randomized clinical trial of goserelin versus surgical ovariectomy in premenopausal patients with receptor-positive metastatic breast cancer: an intergroup study.

S. Martino, N. Robert, J. Ingle, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Antitumor activity and clinical pharmacology of sulofenur in ovarian cancer.

D. Alberts, C. Taylor, D. Roe, 1992, Journal of the National Cancer Institute.

LEUKEMIC INFILTRATION OF THE ORBIT: Report of Three Cases and Literature Review

C. Taylor, S. Kinsey, R. Taylor, 2005, Pediatric hematology and oncology.

Eligibility for Partial Breast Radiotherapy in England.

S. Darby, P. Mcgale, C. Taylor, 2020, Clinical oncology (Royal College of Radiologists (Great Britain)).

Tumorigenic activity of benzo(e)pyrene derivatives on mouse skin and in newborn mice.

D. Jerina, C. Taylor, A. Conney, 1980, Cancer research.

Growth and dissemination of human malignant melanoma cells in mice with severe combined immune deficiency.

T. Grogan, C. Taylor, E. Hersh, 1992, Laboratory investigation; a journal of technical methods and pathology.

CHANGES IN THE EPITHELIUM OF THE CERVIX UTERI

C. Taylor, A. Govan, F. Langley, 1966, The Journal of obstetrics and gynaecology of the British Commonwealth.

Symposium on probable or possible malignant cervical lesions-carcinoma in situ. I. Histology of carcinoma in situ. What is not carcinoma in situ?

C. Taylor, F. Bajardi, M. G. GAUDE FROY, 1961, Acta cytologica.

HYDRADENOMA OF THE VULVA

C. Taylor, A. Deacon, 1952, The Journal of obstetrics and gynaecology of the British Empire.

Diaryl chalcogenides as selective inhibitors of thioredoxin reductase and potential antitumor agents.

G. Paine-Murrieta, C. Taylor, G. Powis, 1997, Anticancer research.

Salivary gland heterotopia: a unique cerebellopontine angle tumor.

C. Taylor, B. Curry, A. Fisher, 1982, Archives of pathology & laboratory medicine.

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

J. Trent, J. Trent, C. Taylor, 1991, British Journal of Cancer.

Induction of a heat shock factor 1-dependent stress response alters the cytotoxic activity of hsp90-binding agents.

I. Benjamin, S. Akinaga, G. Paine-Murrieta, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Randomized trial of adjuvant human interferon gamma versus observation in high-risk cutaneous melanoma: a Southwest Oncology Group study.

V. Sondak, J. Doroshow, C. Taylor, 1995, Journal of the National Cancer Institute.

The histology and cytology of changes in the epithelium of the cervix uteri

C. Taylor, A. Govan, F. Langley, 1969, Journal of clinical pathology.

Effect of Human Pituitary-follicle-stimulating Hormone and Chorionic Gonadotrophin in Stein-Leventhal Syndrome

R. L. Edwards, A. C. Crooke, C. Taylor, 1963 .

Transfection with human thioredoxin increases cell proliferation and a dominant-negative mutant thioredoxin reverses the transformed phenotype of human breast cancer cells.

G. Paine-Murrieta, C. Taylor, G. Powis, 1996, Cancer research.

Evaluation of cisplatin intensity in metastatic non-small-cell lung cancer: a phase III study of the Southwest Oncology Group.

J. Crowley, E. Perez, G. Weiss, 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Treatment of small-cell lung cancer with an alternating chemotherapy regimen given at weekly intervals: a Southwest Oncology Group pilot study.

J. Crowley, T. Miller, R. Livingston, 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

C. Taylor, R. Bukowski, J. Glaspy, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Single umbilical artery is associated with an increased incidence of structural and chromosomal anomalies and growth restriction.

C. Taylor, B. K. Rinehart, D. Terrone, 2000, American journal of perinatology.

Plasmalemmal pH-gradients in drug-sensitive and drug-resistant MCF-7 human breast carcinoma xenografts measured by 31P magnetic resonance spectroscopy.

R. Gillies, M. Altbach, N. Raghunand, 1999, Biochemical pharmacology.

A Phase I and pharmacokinetic study of HMN-214, a novel oral polo-like kinase inhibitor, in patients with advanced solid tumors.

D. V. Von Hoff, C. Taylor, L. Garland, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Cytological diagnosis in gynaecological practice.

C. Taylor, M. Attwood, H. Mclaren, 1958, Lancet.

THE MANAGEMENT OF DYSPLASIA, CARCINOMA IN SITU AND MICROCARCINOMA OF THE CERVIX

C. Taylor, M. Brudenell, B. S. Cox, 1973, The Journal of obstetrics and gynaecology of the British Commonwealth.

Effects of suramin on in vitro growth of fresh human tumors.

C. Taylor, P. Fanta, S. Salmon, 1992, Journal of the National Cancer Institute.

Destabilization of steroid receptors by heat shock protein 90-binding drugs: a ligand-independent approach to hormonal therapy of breast cancer.

S. Akinaga, G. Paine-Murrieta, C. Taylor, 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.

Dysphagia and thoracoabdominal aneurysm

C. Taylor, J. Nightingale, A. Sinha, 2001, Postgraduate medical journal.

CARCINOMA OF THE UTERINE CERVIX, ENDOMETRIUM AND OVARY

C. Taylor, Magnus Haines, 1963 .

Suppression of human lymphoma development in the severe combined immune-deficient mouse by imexon therapy.

T. Grogan, C. Taylor, E. Hersh, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Antiproliferative and antitumor activity of the 2-cyanoaziridine compound imexon on tumor cell lines and fresh tumor cells in vitro.

C. Taylor, E. Hersh, S. Salmon, 1992, Journal of the National Cancer Institute.

Extramedullary Waldenström Macroglobulinemia Presenting as a Subcutaneous Penile Mass

C. Taylor, J. Sahagún, Y. al-Shraideh, 2021, Cureus.

Effects of amifostine and paclitaxel on growth of human ovarian carcinoma xenografts in the severe combined immune-deficient mouse: preliminary results.

C. Taylor, R. Capizzi, C. Johnson, 1996, Seminars in oncology.